Physician profile
James W Edlund
NPI 1144212259
$4,057.87
in general payments reported to CMS, 2019-2025
18 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $423 · 2021: $710 · 2022: $744 · 2023: $298 · 2024: $467 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,473.06 | 2019-2024 | Puraply, Affinity |
| Smith+Nephew, INC. | $1,338.16 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Kerecis Limited | $298.44 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Tactile Systems Technology INC | $222.95 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Reprise Biomedical, INC. | $155.18 | 2024-2025 | Miro3d |
| Osiris Therapeutics INC. | $141.15 | 2019 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2024 | Nuzyra |
| Convatec INC. | $52.22 | 2019-2024 | |
| Kci USA, INC. | $49.58 | 2020-2022 | |
| Solventum Corporation | $34.05 | 2025 | Activ.A.C. |
| Acera Surgical, INC. | $32.93 | 2019 | |
| Mimedx Group, INC. | $23.90 | 2024 | |
| Polynovo North America LLC | $21.40 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $21.09 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Triad Life Sciences INC. | $18.57 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $18.00 | 2019 | |
| Melinta Therapeutics, LLC | $17.05 | 2022 | |
| Hartmann USA, INC. | $15.14 | 2024 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Edlund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.